What is the recommended asthma action plan according to Global Initiative for Asthma (GINA) guidelines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

GINA Asthma Action Plan

All patients with asthma must receive a written asthma action plan that includes daily management instructions, recognition of worsening symptoms, medication adjustments, and clear criteria for seeking emergency care. 1, 2

Core Components of the Action Plan

Green Zone: Asthma is Well-Controlled

Daily preventive actions:

  • Take long-term controller medications every day as prescribed (low-dose ICS or ICS-formoterol depending on severity) 1, 2
  • Avoid identified triggers including tobacco smoke, allergens, irritants, and air pollution 1, 2
  • Monitor symptoms: no daytime symptoms, no nighttime awakening, no activity limitation, minimal or no need for reliever medication 3, 4

Preferred reliever medication:

  • Use as-needed low-dose ICS-formoterol (Track 1 preferred approach), which reduces severe exacerbations by ≥60% compared to SABA alone 2, 5, 6
  • Alternative: as-needed SABA if using Track 2 approach 5, 6

Yellow Zone: Asthma is Getting Worse

Warning signs to recognize:

  • Increased cough, wheeze, chest tightness, or shortness of breath 1
  • Waking at night due to asthma symptoms 1
  • Increased need for reliever medication (using SABA >2 days/week indicates need for controller adjustment) 1
  • Peak flow dropping to 50-80% of personal best (if monitoring PEF) 1
  • Difficulty with usual physical activities 1

Immediate actions:

  • Increase reliever medication: take 2-4 puffs of ICS-formoterol or SABA every 20 minutes for first hour 1, 2
  • Start or increase oral corticosteroids (typically prednisone 40-50mg daily for adults) if symptoms persist or worsen 1, 7
  • Continue controller medications at current or increased dose 1, 2
  • Contact your healthcare provider within 24 hours if not improving 1

Red Zone: Medical Emergency

Danger signs requiring immediate emergency care (call 911 or go to emergency department):

  • Severe breathlessness (difficulty walking or talking due to asthma) 1, 2
  • No improvement or worsening despite taking reliever medication 1
  • Lips or fingernails turning blue 1
  • Drowsiness or confusion 1, 2
  • Peak flow <50% of personal best (if monitoring) 1, 2

Emergency treatment while waiting for help:

  • Give 4-8 puffs of SABA or ICS-formoterol immediately, repeat every 20 minutes 1, 2
  • Start oral corticosteroids immediately if available 1, 2
  • Sit upright, stay calm, do not lie down 1

Essential Self-Management Skills

Patients must demonstrate competency in:

  • Proper inhaler technique with return demonstration to healthcare provider 1, 2
  • Use of spacer/valved holding chamber devices as prescribed 1
  • Understanding difference between "relievers" (quick-relief medications like SABA or ICS-formoterol) and "preventers" (daily controller medications like ICS) 1, 2
  • Self-monitoring of symptoms and peak flow if prescribed 1, 2
  • Recognition of early warning signs specific to the individual patient 1

Medication Adjustment Algorithm

Step-up therapy when asthma is uncontrolled:

  • Verify medication adherence, inhaler technique, and trigger avoidance before increasing medications 1, 5
  • Move to next treatment step if symptoms persist despite correct technique and adherence 3, 4
  • Reassess control after 2-3 months at new treatment level 5, 4

Step-down therapy when asthma is well-controlled:

  • Consider reducing treatment after 3 months of good control 7, 5
  • Reduce ICS dose by 25-50% at 3-month intervals 7, 5
  • Maintain close monitoring during step-down 5, 4

High-Risk Patients Requiring Intensive Monitoring

Patients at increased risk of asthma-related death need special attention:

  • Previous severe exacerbation requiring intubation or ICU admission 1
  • Two or more hospitalizations or >3 emergency department visits in past year 1
  • Using >2 canisters of SABA per month 1
  • Difficulty perceiving airway obstruction or severity of worsening asthma 1
  • Major psychosocial problems, psychiatric disease, or illicit drug use 1
  • Low socioeconomic status or comorbidities 1

These patients should:

  • Use peak flow-based action plans for objective monitoring 1
  • Seek medical care early during any exacerbation 1
  • Have more frequent follow-up appointments 2, 5

Common Pitfalls to Avoid

Do NOT rely on these ineffective home treatments:

  • Drinking large volumes of liquids during exacerbations 1
  • Breathing warm, moist air 1
  • Over-the-counter antihistamines or cold remedies for asthma symptoms 1
  • Doubling ICS dose during exacerbations (not effective; use oral corticosteroids instead) 1

Critical safety point:

  • Never use LABA medications alone without ICS, as this increases risk of asthma-related death 2

Follow-Up and Monitoring Schedule

Regular assessment at each visit should include:

  • Days per week with symptoms and nighttime awakening 1
  • Days per week with activity limitation 1
  • Number of puffs of reliever medication used daily 1
  • Any asthma attacks or unscheduled healthcare visits since last appointment 1
  • Review of peak flow chart if patient monitors at home 1
  • Assessment of medication adherence and barriers 1
  • Demonstration of inhaler technique 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Asthma Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Global Initiative for Asthma Management and Prevention--GINA 2006].

Pneumologie (Stuttgart, Germany), 2007

Research

Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.

American journal of respiratory and critical care medicine, 2022

Research

Update on Asthma Management Guidelines.

Missouri medicine, 2024

Guideline

Inhaled Steroids for Asthma Management in Patients with Chronic MAC Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.